INR 23.21
(4.03%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 923.8 Million INR | 2354.29% |
2022 | -40.98 Million INR | -104.0% |
2021 | 1.02 Billion INR | 100.28% |
2020 | 511.3 Million INR | -68.28% |
2019 | 1.61 Billion INR | -20.78% |
2018 | 2.03 Billion INR | 17.06% |
2017 | 1.73 Billion INR | 6.11% |
2016 | 1.63 Billion INR | -10.32% |
2015 | 1.82 Billion INR | 8.23% |
2014 | 1.68 Billion INR | 1.46% |
2013 | 1.66 Billion INR | -24.28% |
2012 | 2.19 Billion INR | 24.25% |
2011 | 1.76 Billion INR | -9.11% |
2010 | 1.94 Billion INR | 17.99% |
2009 | 1.64 Billion INR | 51.47% |
2008 | 1.08 Billion INR | -16.81% |
2007 | 1.3 Billion INR | 74.52% |
2006 | 749.66 Million INR | 7.42% |
2005 | 697.9 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 243.43 Million INR | -27.99% |
2023 Q2 | 115.52 Million INR | -42.83% |
2023 FY | 923.8 Million INR | 2354.29% |
2023 Q1 | 202.07 Million INR | 523.43% |
2023 Q4 | 338.03 Million INR | 23.84% |
2023 Q3 | 272.97 Million INR | 136.29% |
2022 Q4 | 32.41 Million INR | 124.3% |
2022 FY | -40.98 Million INR | -104.0% |
2022 Q1 | 271.13 Million INR | -22.3% |
2022 Q2 | -221.9 Million INR | -181.84% |
2022 Q3 | -133.36 Million INR | 39.9% |
2021 Q4 | 348.94 Million INR | 7.99% |
2021 FY | 1.02 Billion INR | 100.28% |
2021 Q3 | 323.11 Million INR | 142.88% |
2021 Q2 | 133.03 Million INR | -36.92% |
2021 Q1 | 210.89 Million INR | 48.31% |
2020 Q4 | 142.2 Million INR | -22.35% |
2020 Q1 | 21.22 Million INR | -54.49% |
2020 Q3 | 183.11 Million INR | 8.3% |
2020 Q2 | 169.08 Million INR | 696.51% |
2020 FY | 511.3 Million INR | -68.28% |
2019 Q1 | 477.17 Million INR | 3076.92% |
2019 Q3 | 413.4 Million INR | 17.21% |
2019 FY | 1.61 Billion INR | -20.78% |
2019 Q4 | 46.64 Million INR | -88.72% |
2019 Q2 | 352.7 Million INR | -26.08% |
2018 Q3 | 499.12 Million INR | -0.73% |
2018 Q1 | 451.73 Million INR | 0.0% |
2018 Q4 | 15.02 Million INR | -96.99% |
2018 FY | 2.03 Billion INR | 17.06% |
2018 Q2 | 502.81 Million INR | 11.31% |
2017 FY | 1.73 Billion INR | 6.11% |
2016 FY | 1.63 Billion INR | -10.32% |
2015 Q3 | - INR | 0.0% |
2015 FY | 1.82 Billion INR | 8.23% |
2014 FY | 1.68 Billion INR | 1.46% |
2014 Q3 | - INR | 0.0% |
2013 FY | 1.66 Billion INR | -24.28% |
2012 FY | 2.19 Billion INR | 24.25% |
2011 FY | 1.76 Billion INR | -9.11% |
2010 FY | 1.94 Billion INR | 17.99% |
2009 FY | 1.64 Billion INR | 51.47% |
2008 FY | 1.08 Billion INR | -16.81% |
2007 FY | 1.3 Billion INR | 74.52% |
2006 FY | 749.66 Million INR | 7.42% |
2005 FY | 697.9 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 5.75 Billion INR | 83.956% |
Aurobindo Pharma Limited | 42.2 Billion INR | 97.811% |
Glenmark Life Sciences Limited | 8.97 Billion INR | 89.712% |
Granules India Limited | 6.81 Billion INR | 86.448% |
Indoco Remedies Limited | 1.29 Billion INR | 28.528% |
Achyut Healthcare Limited | 4.43 Million INR | -20715.818% |
Ajanta Pharma Limited | 19.67 Billion INR | 95.305% |
Alkem Laboratories Limited | 19.46 Billion INR | 95.253% |
Alpa Laboratories Limited | 184.49 Million INR | -400.716% |
Brooks Laboratories Limited | 14.44 Million INR | -6297.548% |
AstraZeneca Pharma India Limited | 1.71 Billion INR | 46.212% |
Bajaj HealthCare Limited | - INR | -Infinity% |
Bliss GVS Pharma Limited | 1.23 Billion INR | 24.955% |
Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 98.636% |
Eris Lifesciences Limited | 5.18 Billion INR | 82.172% |
FDC Limited | 2.98 Billion INR | 69.064% |
Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 85.793% |
Gufic Biosciences Limited | 1.32 Billion INR | 30.536% |
Ind-Swift Laboratories Limited | 4.42 Billion INR | 79.102% |
Ipca Laboratories Limited | 7.98 Billion INR | 88.424% |
Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -81.805% |
Krebs Biochemicals & Industries Limited | -151.95 Million INR | 707.939% |
Lasa Supergenerics Limited | -458 Million INR | 301.702% |
Laurus Labs Limited | 3.94 Billion INR | 76.604% |
Lupin Limited | 28.04 Billion INR | 96.706% |
Mankind Pharma Limited | 21.51 Billion INR | 95.707% |
Medicamen Biotech Limited | - INR | -Infinity% |
Medico Remedies Limited | 100.3 Million INR | -821.043% |
Megasoft Limited | -121.1 Million INR | 862.82% |
NATCO Pharma Limited | 25.96 Billion INR | 96.442% |
Piramal Pharma Limited | 4.55 Billion INR | 79.727% |
RPG Life Sciences Limited | 2.29 Billion INR | 59.7% |
Sigachi Industries Limited | 1.47 Billion INR | 37.322% |
Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 99.114% |
Suven Pharmaceuticals Limited | 4.6 Billion INR | 79.951% |
Syncom Formulations (India) Limited | 249.25 Million INR | -270.633% |
Unichem Laboratories Limited | - INR | -Infinity% |
Wanbury Limited | 569.71 Million INR | -62.152% |
Windlas Biotech Limited | 1.29 Billion INR | 28.877% |
ZIM Laboratories Limited | 253.82 Million INR | -263.948% |
Zydus Lifesciences Limited | 43.1 Billion INR | 97.857% |
Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 122.449% |
Divi's Laboratories Limited | 33.08 Billion INR | 97.207% |
Hester Biosciences Limited | 364.81 Million INR | -153.229% |
Procter & Gamble Health Limited | 2.78 Billion INR | 66.841% |
Amrutanjan Health Care Limited | 457.54 Million INR | -101.905% |
Bal Pharma Limited | 233.9 Million INR | -294.942% |
Strides Pharma Science Limited | 5.22 Billion INR | 82.322% |
Venus Remedies Limited | 534.65 Million INR | -72.787% |
Aarti Pharmalabs Limited | 3.12 Billion INR | 70.468% |
Shilpa Medicare Limited | 1.36 Billion INR | 32.385% |
Aarti Drugs Limited | 7.14 Billion INR | 87.077% |
IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 42.146% |
Suven Life Sciences Limited | -1.22 Billion INR | 175.362% |
Ind-Swift Limited | 1.22 Billion INR | 24.647% |
Valiant Laboratories Limited | - INR | -Infinity% |
J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 93.532% |
Solara Active Pharma Sciences Limited | -3.85 Billion INR | 123.977% |
Themis Medicare Limited | 392.58 Million INR | -135.311% |
Hikal Limited | 32.11 Million INR | -2777.004% |
Torrent Pharmaceuticals Limited | 25.33 Billion INR | 96.354% |
Sequent Scientific Limited | - INR | -Infinity% |
Novartis India Limited | 626.5 Million INR | -47.455% |
Wockhardt Limited | -670 Million INR | 237.881% |
Jubilant Pharmova Limited | 5.18 Billion INR | 82.197% |
Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -10086.752% |
Neuland Laboratories Limited | 5.31 Billion INR | 82.629% |
Morepen Laboratories Limited | 4.17 Billion INR | 77.867% |
Kilitch Drugs (India) Limited | 208.05 Million INR | -344.031% |
Mangalam Drugs & Organics Limited | 27.45 Million INR | -3264.433% |